Xencor, Inc. Reports Q3 2026 Financial Results
Xencor, Inc. announced its third-quarter 2026 financial results, reporting revenue of $116.5 million and earnings per share of $0.50, both significantly exceeding analyst expectations.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Xencor, Inc. announced its third-quarter 2026 financial results, reporting revenue of $116.5 million and earnings per share of $0.50, both significantly exceeding analyst expectations.
Multiple financial institutions, including Wells Fargo, RBC Capital Markets, and Wedbush, updated their ratings and price targets for Xencor on November 2, 2026.
Wells Fargo and Barclays have both updated their price targets for Xencor, Inc. following recent clinical updates.
RBC Capital Markets and Wedbush have both increased their price targets for Xencor, maintaining their positive outlooks on the company.
Wedbush Securities updated its price target for Xencor, Inc. to $45 from $30 while maintaining an Outperform rating.